Neurology Search
Neurology Neurology

Conference Reports

Alzheimer’s Association International Conference (AAIC) 2020

27 July 2020 - 31 July 2020

American Headache Society (AHS) 2020 Virtual Annual Scientific Meeting

San Diego, California
13 June 2020 - 13 June 2020

American Academy of Neurology (AAN) 2020 Annual Meeting

Toronto, Ontario
25 April 2020 - 01 May 2020

International Stroke Conference (ISC) 2020

Los Angeles, California
19 February 2020 - 21 February 2020

Alzheimer's Association International Conference (AAIC) 2019

Los Angeles, California, US
14 July 2019 - 18 July 2019

2019 American Academy of Neurology (AAN) Annual Meeting

Philadelphia, Pennsylvania
04 May 2019 - 10 May 2019

American Association for Cancer Research (AACR) Annual Meeting 2019

Atlanta, Georgia
29 March 2019 - 03 April 2019

14th International Symposium on Healthy Aging

16 March 2019 - 17 March 2019

International Stroke Conference 2019 (ISC 2019)

Honolulu, Hawaii, US
06 February 2019 - 08 February 2019

VasCog 2018 (9th International Conference of The International Society of Vascular Behavioural and Cognitive Disorders)

14 November 2018 - 17 November 2018

Alzheimer's Association International Conference (AAIC) 2018

Chicago
22 July 2018 - 26 July 2018

Advances in Medicine 2017

19 May 2018 - 20 May 2018

2018 American Academy of Neurology Annual Meeting (AAN 2018)

Los Angeles, California, US
21 April 2018 - 27 April 2018

International Stroke Conference 2018 (ISC 2018)

Los Angeles, California, US
24 January 2018 - 26 January 2018
Editor's Recommendations
Most Read Articles
Multimodal approach to pain: Answer to acute migraine treatment?
Pearl Toh, 12 Jun 2020
A new combination product (AXS-07), which consists of the triptan rizatriptan and the NSAID* meloxicam, led to rapid and sustained pain relief than treatment with either component alone or placebo in patients with a history of inadequate response to prior acute migraine treatment, according to data from the MOMENTUM study released during the AAN 2020 Meeting.
Aducanumab in Alzheimer’s disease: Does it work?
Pearl Toh, 24 Jun 2020
While aducanumab significantly reduced clinical decline in individuals with early Alzheimer's disease (AD) in one randomized trial, no changes were seen in another identical study — rendering the role of aducanumab in AD inconclusive.
Number, severity of menopausal symptoms may up CV risk
Roshini Claire Anthony, 19 Oct 2020

Women who experience two or more moderate or severe menopausal symptoms may have an elevated risk of cardiovascular disease (CVD) or strokes, according to a study presented at NAMS 2020.